Chemours Co (NYSE:CC) has earned a consensus rating of “Hold” from the fourteen brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $59.22.
A number of analysts recently weighed in on the stock. Barclays reaffirmed a “buy” rating and set a $62.00 target price on shares of Chemours in a report on Tuesday, August 7th. BMO Capital Markets decreased their target price on shares of Chemours from $70.00 to $68.00 and set an “outperform” rating on the stock in a report on Monday, August 6th. SunTrust Banks assumed coverage on shares of Chemours in a report on Tuesday, July 31st. They set a “hold” rating and a $51.00 target price on the stock. Citigroup decreased their target price on shares of Chemours from $69.00 to $64.00 and set a “buy” rating on the stock in a report on Wednesday, July 11th. Finally, ValuEngine lowered shares of Chemours from a “hold” rating to a “sell” rating in a report on Tuesday, July 10th.
Chemours stock traded up $0.07 during midday trading on Thursday, reaching $44.34. 934,600 shares of the stock were exchanged, compared to its average volume of 1,659,769. The company has a current ratio of 2.09, a quick ratio of 1.47 and a debt-to-equity ratio of 3.86. The firm has a market capitalization of $7.96 billion, a PE ratio of 11.67, a price-to-earnings-growth ratio of 0.50 and a beta of 2.84. Chemours has a 52 week low of $42.75 and a 52 week high of $58.08.
The business also recently declared a quarterly dividend, which will be paid on Friday, September 14th. Stockholders of record on Friday, August 17th will be issued a $0.25 dividend. This is a positive change from Chemours’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Thursday, August 16th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.26%. Chemours’s dividend payout ratio is presently 17.80%.
Large investors have recently modified their holdings of the company. Cerebellum GP LLC bought a new position in shares of Chemours in the 2nd quarter worth $175,000. Point72 Asia Hong Kong Ltd bought a new position in shares of Chemours in the 1st quarter worth $178,000. Gofen & Glossberg LLC IL bought a new position in shares of Chemours in the 2nd quarter worth $204,000. Johanson Financial Advisors Inc. bought a new position in shares of Chemours in the 1st quarter worth $206,000. Finally, Gideon Capital Advisors Inc. bought a new position in shares of Chemours in the 2nd quarter worth $209,000. 78.90% of the stock is currently owned by hedge funds and other institutional investors.
Chemours Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.
Featured Article: Closed-End Mutual Funds (CEFs)
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.